Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-017717
Filing Date
2024-10-16
Accepted
2024-10-16 16:58:11
Documents
2
Period of Report
2024-10-14

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1568
2 POA exhibit24-1.txt EX-24.1 2964
  Complete submission text file 0001062993-24-017717.txt   6028
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PHARVARIS N.V. EMMY NOETHERWEG 2 LEIDEN P7 2333 BK
Business Address
Conn Morgan (Reporting) CIK: 0001974124 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40498 | Film No.: 241375212